Håvard Hildeng Hauge
Håvard has directed activities at the company since 2004 and has previous corporate experience as managing director of Biomolex. Hauge is also an accomplished scientist. He received his Ph.D. in biochemistry from the University of Oslo in 1999 for his work on protein structures in relation to membrane permeability in lactic acid bacteria. Dr. Hauge continued this work in a postdoctoral position including one year at EMBL, Heidelberg. His scientific efforts have thus far resulted in several publications in international journals.
Tor Kristian Jenssen
Tor Kristian holds MSc and Ph.D degrees in Computer Sciences. He lectured Informatics at the Norwegian Institute of Technology in 1998 – 1999, was a researcher in the Norwegian Cancer Hospital in 2001 – 2002, and a Board member of two strategic programs at the Norwegian Institute of Technology.
Jorun holds an MSc degree in marketing from The Norwegian School of Marketing. She has over 25 years of experience in the field of business development, marketing and communication. Jorun is responsible for communication and interaction with the patients and doctors in the development of our digital health solutions. Board member in PubGene from 2003-2019.
Amelie drives the company’s devotion to advancing digital health for precision medicine, incl. positioning Coremine Vitae as a reliable partner of the eHealth ecosystem and establishing an effective scaling pipeline. She empowers the teams to build solutions that leverage AI-human collaboration and that emphasize on quality, clinical actionability, patient safety and information security, with optimal agile productivity. Amelie has over 10 years of experience in the eHealth industry, with leading positions in software, product, and business development. She holds a MSc. degree in Bioinformatics from Cranfield University, England, and a MEng. in Health Information Technology (HIT) from Polytech Grenoble, France.